CUSIP: 444863203
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
29,226,843
-
Share change
-
+55,738
-
Total reported value
-
$108,748,699
-
Put/Call ratio
-
61%
-
Price per share
-
$3.72
-
Number of holders
-
83
-
Value change
-
-$1,511,879
-
Number of buys
-
53
-
Number of sells
-
37
Quarterly Holders Quick Answers
What is CUSIP 444863203?
CUSIP 444863203 identifies HGEN - HUMANIGEN INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 444863203:
Institutional Holders of HUMANIGEN INC - COM NEW (HGEN) as of Q4 2021
As of 31 Dec 2021,
HUMANIGEN INC - COM NEW (HGEN) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,226,843 shares.
The largest 10 holders included
Valiant Capital Management, L.P., Murchinson Ltd., BlackRock Inc., VANGUARD GROUP INC, MARSHALL WACE, LLP, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and VOLORIDGE INVESTMENT MANAGEMENT, LLC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.